On October 14, Astera Labs, Inc. fell 3.04% in Regular Trading, trading at $316.645 per share, with turnover of $45.8157 million.
The move was linked to continued pressure after Northland Securities downgraded the stock to market perform from outperform, while profit-taking ahead of the company’s November 3 third-quarter results kept near-term sentiment subdued.
Recent market coverage indicated the downgrade remained the main catalyst behind the latest weakness, even as broader analyst sentiment stayed constructive with an average rating of overweight and a mean target price of $416.78. The market is also expecting next-quarter EPS of $0.83, suggesting consensus forecasts have not materially deteriorated, but the single rating cut has continued to weigh on trading into earnings.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments